Clinical Trial Update: CMAB vs IMAB in Metastatic Prostate Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing CMAB and IMAB in metastatic prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CMAB
• IMAB

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Prostate Cancer | Phase 4 | Status: WITHDRAWN